KaiDi Co. announced that its robot-related products are still in the development phase and will not generate revenue in the short term. The company's stock experienced significant price fluctuations, prompting this clarification. Separately, Hanyu Pharmaceutical signed a framework agreement for peptide raw material sales amounting to at least 327 million yuan, and the news also mentioned global free access to ChatGPT Plus and other unrelated financial news. AI
排序理由 The cluster contains multiple unrelated news items, including a clarification from KaiDi Co. about its product development status and a separate financial agreement by Hanyu Pharmaceutical, making it a digest rather than a single coherent story.
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →